Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Florida Biotech LLC currently has 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This action is being processed within 1 distinct art unit, indicating a specific technical focus for the company's current intellectual property efforts. The prosecution is being handled by JUDITH MARIE KAMM, who is the only examiner currently assigned to the portfolio.
As the busiest examiner for the company, JUDITH MARIE KAMM is responsible for the busiest examiner pending action. Because there is only a single pending office action in the entire portfolio, this examiner manages the totality of the company's active workload at the USPTO. This centralization within the Biotechnology & Pharmaceuticals sector simplifies the communication path for the company and allows for a more direct interaction with the office.
The presence of a single pending action suggests a highly targeted approach to patenting within this technical field. With only a single distinct examiner and a single distinct art unit involved, the company can focus its resources on meeting the specific requirements of the assigned official. The busiest examiner pending action is the sole determining factor for the company's current progress in securing patent rights. Practitioners should prioritize understanding the specific examination style of JUDITH MARIE KAMM to advance this application.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KAMM, JUDITH MARIE | 1 | 42.9% | +57.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19058174 | NATURAL OIL-BASED WATER SOLUBLE BIOCIDE | KAMM, JUDITH MARIE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19058174 | NATURAL OIL-BASED WATER SOLUBLE BIOCIDE | KAMM, JUDITH MARIE | — |
| Art Unit | Apps |
|---|---|
| 1611 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19058174 | NATURAL OIL-BASED WATER SOLUBLE BIOCIDE | KAMM, JUDITH MARIE | 1611 | §103§112Other | Non-Final OA | — | Pending | Feb 20, 2025 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialFlorida Biotech LLC has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Judith Marie Kamm has the most, with 1 of Florida Biotech LLC's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
